StemRIM is a drug discovery research and development-oriented biotech company originating from Osaka University. It was established in 2006 with the aim of developing a myelomulti-active stem cell recruitment factor as a pharmaceutical product, which was identified by Professor Tamai and his colleagues at the Graduate School of Medicine, Osaka University. Since then, through joint research with Osaka University, StemRIM has been consistently worked on the development of "regeneration-inducing medicine", which is medicine promoting functional tissue regeneration and enabling the treatment of intractable diseases. StenRIM is continuing to take on the challenge of becoming a world-leading bioventure with the corporate mission of "overcoming intractable diseases with regeneration-inducing medicine.
| Website | https://stemrim.com |
| Revenue | $21.4 million |
| Employees | 7 (1 on RocketReach) |
| Founded | 2006 |
| Address | 7-7-15 Saito-asagi, Ibaraki City, Osaka, JP |
| Phone | +81 72-648-7152 |
| Industry | Retail, Business Services General, Product Research, Business Services, Data and Analytics, Design |
| Keywords | Drug Discovery, Stem Cell Therapy, Biotechnology, Pharmaceutical Research, Cell Therapy, Myeloma Treatment, Drug Development, Biopharma, Regenerative Medicine, Research And Development, Hematology, Oncology, Clinical Trials, Pharmaceutical, Cancer Research, Life Sciences, Preclinical Studies, Molecular Biology |
| Competitors | Thermo Fisher Scientific, GRAIL, Elekta, Benchling, Sema4, Synthego Corporation, Mendel.ai, Lucence, GENOOX, Inflect Health +34 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies |
Looking for a particular Stemrim employee's phone or email?
The Stemrim annual revenue was $21.4 million in 2026.
1 people are employed at Stemrim.
The NAICS codes for Stemrim are [54171, 541, 54, 5417, 541713].
The SIC codes for Stemrim are [87, 873].